September 20, 2021
Takara Bio Europe AB (TBEAB) is proud to officially announce a partnership with the Boston IVF Fertility Center (Boston IVF) headquartered in Waltham, Massachusetts, USA. This partnership gives TBEAB access to discarded starting material for the derivation of clinical-grade hES cell lines for cell therapy research. "When we set off to establish our first clinical-grade [...]
September 20, 2021
CARLSBAD, Calif. – Cell culture laboratories working with CO2 incubators and water baths can now benefit from a new product designed to help safeguard incubators from water-borne contaminants, saving scientists time and labor while reducing the need for hazardous chemical solutions. When placed into any CO2 incubator water pan or laboratory water bath, the Thermo Scientific [...]
Genomenon Announces Collaboration to Accelerate Genetic Diagnosis for Rare Disease Patients
September 20, 2021
Genomenon to Make Essential Genomic Data for Rare Diseases Available to Genetic Testing Labs Worldwide Genomenon, Inc.®, an AI-driven genomics company, today announced a collaboration with Alexion, AstraZeneca Rare Disease that will make critical information needed for the diagnosis and treatment for a set of rare diseases more readily accessible. The goal of this collaboration is to [...]
Illumina Ventures Closes $325 Million Fund
September 20, 2021
Genomics-Focused Fund Will Support Start-Ups in Healthcare Innovation San Francisco – Illumina Ventures, an independently-managed, healthcare-focused venture firm, announced today the closing of its second investment fund with total commitments of $325 million, bringing its total capital under management to $560 million. The latest fund is anchored by Illumina, Inc. (Nasdaq: ILMN), with the majority [...]
Illumina reaffirms commitment to the National Project of Bio Big Data in Korea
September 20, 2021
MELBOURNE, Australia -- Illumina, Inc. (NASDAQ: ILMN) today announced that the National Project of Bio Big Data in Korea has selected Illumina technology for the second pilot project in their effort to work towards establishing a national digital library on health and genome data by 2028. The multi-ministerial project is overseen by the Ministry of Health [...]
September 20, 2021
Thomas H. Lee Partners to acquire the automation business for $3 billion in cash Transaction proceeds will be used to accelerate growth of life sciences business CHELMSFORD, Mass. -- Brooks Automation, Inc. (Nasdaq: BRKS) today announced that it has entered into a definitive agreement to sell its Semiconductor Solutions Group business (or "automation business") to Thomas H. [...]
PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend
September 17, 2021
WALTHAM, Mass.-- PerkinElmer, Inc. (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science antibodies and reagents for a total consideration of approximately $5.25 billion. The acquisition, the largest in PerkinElmer’s history, further expands the Company’s life science franchise into high-growth [...]
September 16, 2021
Merck today announced that Petra Wicklandt will take over the leadership of the new Merck Group Function “Corporate Sustainability, Quality and Trade Compliance”, effective October 2021 Current Head of Corporate Affairs Petra Wicklandt will lead the new function Head of Environment, Health, Safety and Quality Andreas Kruse will retire as planned at the end of [...]
September 16, 2021
Alpha MOS takes a new step in the expanded use of its database AroChemBase, by signing its first sales of licenses with Shimadzu Japan, one of the world leaders in the manufacture of analysis tools by gas chromatography. This technology called "GC" - the same as the one used by Alpha MOS for its artificial [...]
Repligen Announces Agreement to Acquire Avitide Inc.
September 16, 2021
Proposed acquisition strengthens Repligen’s Proteins business Adds a market leader in affinity ligand discovery and development and complements established partnership with Navigo GmbH Strategically moves Repligen into affinity resin solutions for gene therapy Avitide is expected to contribute approximately $10 million in revenue in 2022 and be accretive to Repligen’s adjusted earnings per share in [...]
